M. K. Proteins Limited (NSE:MKPL)
India · Delayed Price · Currency is INR 4.970
+0.010 (0.20%)
Jun 19, 2026, 1:07 PM IST
M. K. Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,829 | 2,677 | 2,456 | 3,149 | 2,559 |
Other Revenue | - | - | - | - | 0.57 |
| 3,829 | 2,677 | 2,456 | 3,149 | 2,559 | |
Revenue Growth (YoY) | 43.02% | 9.01% | -22.01% | 23.02% | -17.74% |
Cost of Revenue | 3,684 | 2,397 | 2,164 | 2,852 | 2,383 |
Gross Profit | 144.45 | 279.69 | 291.41 | 296.73 | 176.15 |
Selling, General & Admin | 30.28 | 27.67 | 27.88 | 17.75 | 19.07 |
Other Operating Expenses | -2.59 | 127.82 | 94.03 | 104.45 | - |
Operating Expenses | 32.05 | 159.01 | 127.19 | 130.4 | 28.2 |
Operating Income | 112.41 | 120.69 | 164.21 | 166.33 | 147.95 |
Interest Expense | -18.52 | -11.05 | -10.65 | -18.42 | -8.33 |
Interest & Investment Income | - | - | 0.1 | 0.12 | 0.3 |
Currency Exchange Gain (Loss) | - | - | - | 1.19 | - |
Other Non Operating Income (Expenses) | - | - | 0.13 | 0.36 | -0 |
EBT Excluding Unusual Items | 93.89 | 109.64 | 153.79 | 149.58 | 139.92 |
Gain (Loss) on Sale of Investments | - | 4.59 | 0.36 | 0.09 | 0.5 |
Gain (Loss) on Sale of Assets | - | 0.29 | - | - | - |
Other Unusual Items | - | - | 0.54 | 0.23 | - |
Pretax Income | 93.89 | 114.51 | 154.7 | 149.9 | 140.42 |
Income Tax Expense | 25.6 | 30.54 | 42.58 | 40.55 | 38.58 |
Net Income | 68.29 | 83.97 | 112.12 | 109.35 | 101.84 |
Net Income to Common | 68.29 | 83.97 | 112.12 | 109.35 | 101.84 |
Net Income Growth | -18.68% | -25.10% | 2.54% | 7.37% | -1.97% |
Shares Outstanding (Basic) | 379 | 375 | 375 | 375 | 375 |
Shares Outstanding (Diluted) | 379 | 375 | 375 | 375 | 375 |
Shares Change (YoY) | 1.07% | - | - | - | 0.01% |
EPS (Basic) | 0.18 | 0.22 | 0.30 | 0.29 | 0.27 |
EPS (Diluted) | 0.18 | 0.22 | 0.30 | 0.29 | 0.27 |
EPS Growth | -18.18% | -26.35% | 3.00% | 6.89% | -1.99% |
Free Cash Flow | 35.39 | -183.51 | 265.13 | -58.8 | -116.95 |
Free Cash Flow Per Share | 0.09 | -0.49 | 0.71 | -0.16 | -0.31 |
Gross Margin | 3.77% | 10.45% | 11.87% | 9.42% | 6.88% |
Operating Margin | 2.94% | 4.51% | 6.69% | 5.28% | 5.78% |
Profit Margin | 1.78% | 3.14% | 4.57% | 3.47% | 3.98% |
Free Cash Flow Margin | 0.92% | -6.86% | 10.80% | -1.87% | -4.57% |
EBITDA | 116.77 | 123.57 | 168.87 | 173.91 | 157.08 |
EBITDA Margin | 3.05% | 4.62% | 6.88% | 5.52% | 6.14% |
D&A For EBITDA | 4.36 | 2.88 | 4.66 | 7.58 | 9.13 |
EBIT | 112.41 | 120.69 | 164.21 | 166.33 | 147.95 |
EBIT Margin | 2.94% | 4.51% | 6.69% | 5.28% | 5.78% |
Effective Tax Rate | 27.26% | 26.67% | 27.52% | 27.05% | 27.47% |
Revenue as Reported | 3,831 | 2,682 | 2,460 | 3,154 | 2,560 |
Advertising Expenses | - | 0.22 | - | 0.04 | 0.02 |